Form D · Other Health Care

TransEngen Inc

Norwalk, CT · CIK 0001401509

Offering snapshot reported Aug 10, 2010 · SEC filing

Reported sold
$2.5M
Offering amount: $2.5M
Investors reported
6
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jul 27, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 10, 2010Initial$2,500,000No comparison6SEC filing
Jul 15, 2009Amendment$1,999,350$649,350vs Apr 29, 20099SEC filing
Apr 29, 2009Initial$1,350,000No comparisonNot reportedSEC filing
Mar 4, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 29, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-146158

Source: Form D, filed Aug 10, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Anthony Roger Francoline Director, Executive
Athanasios Hasiotis Director
Gregory R Morris Director, Executive
Randall Schmidt Director
Roy H Trice Jr. Director
Roy A. Trice, Jr. Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
15 Oakwood Avenue 2 Nd Floor
Norwalk, CT, 06850